One thing you mentioned, Mr. Ireland, which I found interesting, was that last year you were able to fund only 16 of the 30 new research applications. One thing I've asked every time we've had different disease groups before this committee was how many good ideas are being left off the table. I like to try to put it in a fiscal context to give us an idea of what type of investment is required to really put all our hard energy into this.
For Parkinson's, I understand the CIHR last year invested $9 million, with $72 million since the year 2000. So with a $9 million investment, how many applications do you know that we're able to touch, and what percentage of them do you believe we're not able to get to? Of the ones we're not getting to, is it your sense that there are some very interesting concepts that we're not able to examine?